BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
glucose metabolic process
,
Arthritis
,
Breast
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
establishment of mitotic spindle orientation
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Myocardial ischemia
Alpha-1-antitrypsin deficiency
Helicobacter pylori gastrointestinal tract infection
Vesicular stomatitis Indiana virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CP 724714
flavopiridol
AT 7519
CGP 60474
PHA 793887
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
ife-2
MIR122
LIN52
NOP2
AURKB
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Interplay of genetic pathways in C.elegans treated with humic substances
Roundworms (C. elegans) N2 and AB1 strains cultured on agar plates, axenic liquid, and back on agar
Ash-2 knockdown affects on aging in C. elegans
Whole worms of C. elegans with wildtype and alh-6 mutation at L4 larval and d3 adult stages
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for establishment of mitotic spindle orientation
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ